Dr. Christopher Alfred Lobaito, MD

Dr. Lobaito practices at Chilton Medical Center in Pompton Plains, New Jersey, part of Atlantic Health System.

Dr. Lobaito's NPI, 1730445701, was assigned on April 4, 2012. Dr. Lobaito holds New Jersey license 25MA09047300.

Dr. Lobaito's primary practice is Chilton Medical Center, at 97 West Parkway, Pompton Plains, NJ 07444 in Morris County. The practice phone is (973) 831-5000.

Dr. Lobaito's primary practice is Chilton Medical Center in Pompton Plains, New Jersey, part of Atlantic Health System. Dr. Lobaito is also affiliated with NYC Health + Hospitals/Metropolitan. The medical group on file is Emergency Physician Associates of North Jersey.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lobaito practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Lobaito's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Lobaito is licensed in New Jersey.

CMS data shows 830 Medicare services from Dr. Lobaito across 3 procedure codes in 2024, for 760 Medicare patients. Medicare paid $121,140 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 760 Medicare patients who saw Dr. Lobaito in 2024. The largest group is 75 to 84, with 291 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lobaito's median patient age at 57, with 53% women.

In 2024, Dr. Lobaito wrote 157 Medicare Part D claims for 113 patients. 96% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $163 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Lobaito for performance year 2024, reported individually.

CMS Open Payments shows 7 general payments to Dr. Lobaito from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $106.